TMDX TransMedics Group, Inc.

80.28USD-3.27%Mkt Cap: 2.77B $P/E: 20.80

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides…

Key Statistics

Company
Market Cap2.77B USD
Enterprise Value3.16B USD
Revenue (TTM)668.47M USD
Gross Profit362.81M USD
Net Income (TTM)190.29M USD
Revenue/Share19.47 USD
Last Price80.28 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees898
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)20.80
P/E (Forward)34.93
PEG0.68
EV/EBITDA27.35
EV/Revenue4.73
P/S4.13
P/B5.33
EPS (TTM)3.86
EPS (Forward)2.28
52W Range
60.1021% of range156.00
52W High156.00 USD
52W Low60.10 USD
Profitability
Gross Margin59.92%
Oper. Margin12.50%
EBITDA Margin17.30%
Profit Margin31.43%
ROE40.22%
ROA17.81%
Growth
Revenue Growth20.70%
Earnings Growth-55.80%
Cash Flow & Leverage
Operating CF192.84M USD
CapEx (TTM)59.25M USD
FCF Margin6.66%
FCF Yield1.60%
Net Debt395.04M USD
Net Debt/EBITDA3.42
Balance Sheet
Debt/Equity1.10
Current Ratio6.63
Quick Ratio5.87
Book Value/Sh14.96 USD
Cash/Share13.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)97.30 USD
Upside (mean)+21.2%
Target Range65.00 USD – 125.00 USD
65.00+21.2% to mean125.00
# Analysts10
Ownership
Shares Out.34.56M
Float33.56M
Insiders3.64%
Institutions102.91%
Short Interest
Short Ratio11.4d
Short % Float35.82%
Short % Out.23.01%
Shares Short7.98M
Short (prev mo.)7.91M
Technical
SMA 5085.25 (-5.8%)
SMA 20099.98 (-19.7%)
Beta1.88
S&P 52W Chg14.58%
Avg Vol (30d)701.96K
Avg Vol (10d)681.02K
Technical Indicators
RSI (14)44.0
MACD-0.9717
MACD Signal-0.1610
MACD Hist.-0.8107
BB Upper90.89 USD
BB Middle84.77 USD
BB Lower78.66 USD
BB Width14.43%
ATR (14)4.303 USD
Vol Ratio (20d)0.77x